Skip to main content

Program in Cancer Biology

Rachelle Johnson, Ph.D.

Associate Professor of Medicine, Divison of Hematology and Oncology
Program Director & Director of Graduate Studies, Program in Cancer Biology

The Johnson lab research focuses on mechanisms that regulate breast cancer progression, tumor dissemination to bone, and entry and exit from dormancy in the bone marrow, with a particular interest in the role of parathyroid hormone-related protein (PTHrP) and tumor-immune interactions in the bone marrow. The lab also studies mechanisms of drug-induced bone loss and fracture prevention in patients receiving bone-damaging cancer therapies, particularly in patients receiving immunotherapy.